ArticlePLoS biology2026
Engineering inter-kingdom adrenergic signaling in commensals couples host stress hormone sensing to programmable biological outputs.
Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Harnessing pathogen stress-hormone sensing for living medicines.PLoS biology · 2026Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Host stress is associated with elevated catecholamine neurohormones that influence gut physiology and host-microbe interactions, yet how bacterial systems detect and interpret these signals remains incompletely understood. Enteric pathogens exploit inter-kingdom adrenergic signaling to sense host-derived norepinephrine and epinephrine, but whether such pathways can be rationally rewired to produce predictable, programmable outputs has not been systematically explored. Here, we reconstitute adrenergic signaling in Escherichia coli Nissle 1917 by repurposing the enterohemorrhagic E. coli QseBC two-component system. Transcriptomic profiling revealed robust catecholamine-dependent activation of QseBC-regulated pathways in the engineered strain. Guided by these data, we redesigned a QseBC-responsive promoter through rational truncation, sigma-factor replacement, and optimization of QseBC expression, generating a synthetic promoter with enhanced sensitivity and dose-dependent responsiveness to stress hormones. Structure-guided mutagenesis of the QseC sensor kinase identified key residues required for catecholamine recognition, providing mechanistic insight into adrenergic hormone sensing. To demonstrate functional signal transduction beyond transcriptional reporting, we coupled the sensing module to a secretion cassette encoding a corticotropin-releasing factor (CRF) receptor antagonist as a model bioactive output and validated bioactivity in vitro. Together, this work elucidates principles governing bacterial stress hormone sensing and demonstrates how inter-kingdom signaling pathways can be engineered to yield programmable biological outputs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.